##gff-version 3
##sequence-region P35520 1 551
P35520	UniProtKB	Chain	1	551	.	.	.	ID=PRO_0000167133;Note=Cystathionine beta-synthase	
P35520	UniProtKB	Domain	418	476	.	.	.	Note=CBS;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00703	
P35520	UniProtKB	Region	256	260	.	.	.	Note=Pyridoxal phosphate binding;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11483494,ECO:0000269|PubMed:12173932;Dbxref=PMID:11483494,PMID:12173932	
P35520	UniProtKB	Metal binding	52	52	.	.	.	Note=Iron (heme axial ligand);Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11483494,ECO:0000269|PubMed:12173932;Dbxref=PMID:11483494,PMID:12173932	
P35520	UniProtKB	Metal binding	65	65	.	.	.	Note=Iron (heme axial ligand);Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11483494,ECO:0000269|PubMed:12173932;Dbxref=PMID:11483494,PMID:12173932	
P35520	UniProtKB	Binding site	149	149	.	.	.	Note=Pyridoxal phosphate;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11483494,ECO:0000269|PubMed:12173932;Dbxref=PMID:11483494,PMID:12173932	
P35520	UniProtKB	Binding site	349	349	.	.	.	Note=Pyridoxal phosphate;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11483494,ECO:0000269|PubMed:12173932;Dbxref=PMID:11483494,PMID:12173932	
P35520	UniProtKB	Modified residue	27	27	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:21406692;Dbxref=PMID:21406692	
P35520	UniProtKB	Modified residue	119	119	.	.	.	Note=N6-(pyridoxal phosphate)lysine;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11483494,ECO:0000269|PubMed:12173932;Dbxref=PMID:11483494,PMID:12173932	
P35520	UniProtKB	Modified residue	199	199	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
P35520	UniProtKB	Cross-link	211	211	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17087506;Dbxref=PMID:17087506	
P35520	UniProtKB	Alternative sequence	518	518	.	.	.	ID=VSP_001217;Note=In isoform 2. Y->SQDQAWAGVVGGPAD;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P35520	UniProtKB	Natural variant	18	18	.	.	.	ID=VAR_046921;Note=Functional polymorphism%3B associated with 1/3 to 2/3 the enzyme activity of the wild-type. R->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16205833;Dbxref=dbSNP:rs201827340,PMID:16205833	
P35520	UniProtKB	Natural variant	49	49	.	.	.	ID=VAR_008049;Note=In CBSD%3B decreased expression%3B no effect on cystathionine beta-synthase activity%3B increased homotetramer formation. P->L;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12124992,ECO:0000269|PubMed:20506325,ECO:0000269|PubMed:23974653;Dbxref=dbSNP:rs148865119,PMID:12124992,PMID:20506325,PMID:23974653	
P35520	UniProtKB	Natural variant	58	58	.	.	.	ID=VAR_008050;Note=In CBSD%3B linked with V-114%3B 18%25 of activity. R->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10408774;Dbxref=dbSNP:rs555959266,PMID:10408774	
P35520	UniProtKB	Natural variant	65	65	.	.	.	ID=VAR_021790;Note=In CBSD%3B decreased cystathionine beta-synthase activity%3B inhibited by AdoMet and AdoHcy%3B decreased homotetramer formation. H->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11359213,ECO:0000269|PubMed:20506325;Dbxref=dbSNP:rs1191141364,PMID:11359213,PMID:20506325	
P35520	UniProtKB	Natural variant	69	69	.	.	.	ID=VAR_046922;Note=A->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15489334;Dbxref=dbSNP:rs17849313,PMID:15489334	
P35520	UniProtKB	Natural variant	78	78	.	.	.	ID=VAR_002171;Note=In CBSD%3B severe form%3B associated in cis with N-102%3B decreased cystathionine beta-synthase activity%3B decreased homotetramer formation. P->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:20506325,ECO:0000269|PubMed:7981678;Dbxref=dbSNP:rs786204608,PMID:20506325,PMID:7981678	
P35520	UniProtKB	Natural variant	85	85	.	.	.	ID=VAR_008051;Note=In CBSD%3B loss of cystathionine beta-synthase activity. G->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12007221,ECO:0000269|PubMed:23981774;Dbxref=dbSNP:rs863223435,PMID:12007221,PMID:23981774	
P35520	UniProtKB	Natural variant	87	87	.	.	.	ID=VAR_074590;Note=In CBSD%3B decreased cystathionine beta-synthase activity%3B increased aggregation. T->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23981774;Dbxref=PMID:23981774	
P35520	UniProtKB	Natural variant	88	88	.	.	.	ID=VAR_002172;Note=In CBSD. P->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7762555;Dbxref=PMID:7762555	
P35520	UniProtKB	Natural variant	101	101	.	.	.	ID=VAR_021791;Note=In CBSD%3B common mutation in Irish population%3B loss of activity. L->P;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12124992,ECO:0000269|PubMed:14635102,ECO:0000269|PubMed:9889017;Dbxref=dbSNP:rs786204757,PMID:12124992,PMID:14635102,PMID:9889017	
P35520	UniProtKB	Natural variant	102	102	.	.	.	ID=VAR_002173;Note=In CBSD%3B associated in cis with R-78%3B decreased cystathionine beta-synthase activity%3B decreased homotetramer formation. K->N;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:20506325,ECO:0000269|PubMed:7981678;Dbxref=dbSNP:rs786204609,PMID:20506325,PMID:7981678	
P35520	UniProtKB	Natural variant	102	102	.	.	.	ID=VAR_008052;Note=K->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11013450;Dbxref=dbSNP:rs34040148,PMID:11013450	
P35520	UniProtKB	Natural variant	109	109	.	.	.	ID=VAR_021792;Note=In CBSD%3B loss of activity. C->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12124992;Dbxref=dbSNP:rs778220779,PMID:12124992	
P35520	UniProtKB	Natural variant	114	114	.	.	.	ID=VAR_002174;Note=In CBSD%3B mild form%3B when linked with W-58 severe form%3B decreased cystathionine beta-synthase activity%3B decreases homotetramer formation by promoting formation of larger aggregates. A->V;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11359213,ECO:0000269|PubMed:20506325,ECO:0000269|PubMed:8353501;Dbxref=dbSNP:rs121964964,PMID:11359213,PMID:20506325,PMID:8353501	
P35520	UniProtKB	Natural variant	116	116	.	.	.	ID=VAR_008053;Note=In CBSD. G->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8803779;Dbxref=dbSNP:rs760214620,PMID:8803779	
P35520	UniProtKB	Natural variant	121	121	.	.	.	ID=VAR_008054;Note=In CBSD. R->C;Dbxref=dbSNP:rs775992753	
P35520	UniProtKB	Natural variant	121	121	.	.	.	ID=VAR_008055;Note=In CBSD. R->H;Dbxref=dbSNP:rs770095972	
P35520	UniProtKB	Natural variant	121	121	.	.	.	ID=VAR_008056;Note=In CBSD%3B mild form. R->L;Dbxref=dbSNP:rs770095972	
P35520	UniProtKB	Natural variant	125	125	.	.	.	ID=VAR_046923;Note=In CBSD. R->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11553052;Dbxref=PMID:11553052	
P35520	UniProtKB	Natural variant	125	125	.	.	.	ID=VAR_002175;Note=In CBSD%3B severe form%3B when linked with D-131 moderate form%3B loss of cystathionine beta-synthase activity%3B decreased homotetramer formation. R->Q;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12124992,ECO:0000269|PubMed:20506325,ECO:0000269|PubMed:7762555,ECO:0000269|PubMed:7849717;Dbxref=dbSNP:rs781444670,PMID:12124992,PMID:20506325,PMID:7762555,PMID:7849717	
P35520	UniProtKB	Natural variant	125	125	.	.	.	ID=VAR_008057;Note=In CBSD%3B exhibits an activity lower than 4%25 of the wild-type enzyme%3B absent capacity to form multimeric quaternary structure. R->W;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12815602,ECO:0000269|PubMed:16429402;Dbxref=dbSNP:rs886057100,PMID:12815602,PMID:16429402	
P35520	UniProtKB	Natural variant	126	126	.	.	.	ID=VAR_008058;Note=In CBSD%3B loss of activity. M->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10408774;Dbxref=PMID:10408774	
P35520	UniProtKB	Natural variant	128	128	.	.	.	ID=VAR_008059;Note=In CBSD. E->D;Dbxref=dbSNP:rs374593242	
P35520	UniProtKB	Natural variant	131	131	.	.	.	ID=VAR_002176;Note=In CBSD%3B linked with Q-125%3B loss of activity. E->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7849717;Dbxref=PMID:7849717	
P35520	UniProtKB	Natural variant	139	139	.	.	.	ID=VAR_008060;Note=In CBSD%3B mild form. G->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7611293;Dbxref=dbSNP:rs121964965,PMID:7611293	
P35520	UniProtKB	Natural variant	143	143	.	.	.	ID=VAR_021793;Note=In CBSD%3B 4%25 of activity%3B stable. I->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15146473;Dbxref=dbSNP:rs370167302,PMID:15146473	
P35520	UniProtKB	Natural variant	144	144	.	.	.	ID=VAR_002177;Note=In CBSD%3B loss of cystathionine beta-synthase activity%3B impaired stimulation by AdoMet and AdoHcy%3B decreased homotetramer formation. E->K;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10215408,ECO:0000269|PubMed:11359213,ECO:0000269|PubMed:12124992,ECO:0000269|PubMed:20506325,ECO:0000269|PubMed:7611293,ECO:0000269|PubMed:9156316;Dbxref=dbSNP:rs121964966,PMID:10215408,PMID:11359213,PMID:12124992,PMID:20506325,PMID:7611293,PMID:9156316	
P35520	UniProtKB	Natural variant	145	145	.	.	.	ID=VAR_002178;Note=In CBSD. P->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8353501;Dbxref=dbSNP:rs121964963,PMID:8353501	
P35520	UniProtKB	Natural variant	148	148	.	.	.	ID=VAR_008061;Note=In CBSD%3B loss of cystathionine beta-synthase activity%3B impaired stimulation by AdoMet and AdoHcy%3B loss of homotetramer formation. G->R;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15146473,ECO:0000269|PubMed:16429402,ECO:0000269|PubMed:20506325;Dbxref=dbSNP:rs755952006,PMID:15146473,PMID:16429402,PMID:20506325	
P35520	UniProtKB	Natural variant	151	159	.	.	.	ID=VAR_008063;Note=In CBSD. Missing	
P35520	UniProtKB	Natural variant	151	151	.	.	.	ID=VAR_008062;Note=In CBSD. G->R;Dbxref=dbSNP:rs373782713	
P35520	UniProtKB	Natural variant	152	152	.	.	.	ID=VAR_008064;Note=In CBSD%3B severe form. I->M	
P35520	UniProtKB	Natural variant	154	154	.	.	.	ID=VAR_046924;Note=In CBSD%3B protein expression is comparable to wild-type%3B significant decrease of enzyme activity. L->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16205833;Dbxref=PMID:16205833	
P35520	UniProtKB	Natural variant	155	155	.	.	.	ID=VAR_008065;Note=In CBSD%3B complete loss of activity%3B severely affects homotetramer formation by promoting formation of larger aggregates. A->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11359213;Dbxref=dbSNP:rs1429138569,PMID:11359213	
P35520	UniProtKB	Natural variant	155	155	.	.	.	ID=VAR_046925;Note=In CBSD%3B protein expression is comparable to wild-type%3B significant decrease of enzyme activity. A->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16205833;Dbxref=PMID:16205833	
P35520	UniProtKB	Natural variant	165	165	.	.	.	ID=VAR_002179;Note=In CBSD%3B severe form%3B protein expression is comparable to wild-type%3B loss of cystathionine beta-synthase activity%3B no effect on homotetramer formation. C->Y;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10215408,ECO:0000269|PubMed:11359213,ECO:0000269|PubMed:12124992,ECO:0000269|PubMed:20506325,ECO:0000269|PubMed:7635485;Dbxref=dbSNP:rs1347651454,PMID:10215408,PMID:11359213,PMID:12124992,PMID:20506325,PMID:7635485	
P35520	UniProtKB	Natural variant	168	168	.	.	.	ID=VAR_046926;Note=In CBSD. V->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15993874;Dbxref=PMID:15993874	
P35520	UniProtKB	Natural variant	168	168	.	.	.	ID=VAR_002180;Note=In CBSD. V->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8528202;Dbxref=dbSNP:rs121964970,PMID:8528202	
P35520	UniProtKB	Natural variant	173	173	.	.	.	ID=VAR_046927;Note=In CBSD%3B presents 40%25 of the wild-type activity%3B highly reduced capacity to form multimeric quaternary structure. M->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16429402;Dbxref=PMID:16429402	
P35520	UniProtKB	Natural variant	173	173	.	.	.	ID=VAR_066098;Note=In CBSD%3B loss of activity. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21520339;Dbxref=PMID:21520339	
P35520	UniProtKB	Natural variant	176	176	.	.	.	ID=VAR_008066;Note=In CBSD%3B severe form%3B loss of cystathionine beta-synthase activity%3B inhibited by AdoMet%3B severely decreases homotetramer formation by promoting formation of larger aggregates. E->K;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11359213,ECO:0000269|PubMed:20506325,ECO:0000269|PubMed:9266356;Dbxref=dbSNP:rs762065361,PMID:11359213,PMID:20506325,PMID:9266356	
P35520	UniProtKB	Natural variant	180	180	.	.	.	ID=VAR_008067;Note=In CBSD%3B decreased cystathionine beta-synthase activity%3B decreases homotetramer formation. V->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20506325;Dbxref=PMID:20506325	
P35520	UniProtKB	Natural variant	191	191	.	.	.	ID=VAR_008068;Note=In CBSD%3B moderate and severe forms%3B loss of cystathionine beta-synthase activity%3B absent capacity to form multimeric quaternary structure. T->M;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12815602,ECO:0000269|PubMed:15993874,ECO:0000269|PubMed:16429402,ECO:0000269|PubMed:20506325;Dbxref=dbSNP:rs121964973,PMID:12815602,PMID:15993874,PMID:16429402,PMID:20506325	
P35520	UniProtKB	Natural variant	198	198	.	.	.	ID=VAR_008069;Note=In CBSD. D->V	
P35520	UniProtKB	Natural variant	200	200	.	.	.	ID=VAR_066099;Note=In CBSD. P->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21520339;Dbxref=dbSNP:rs758712880,PMID:21520339	
P35520	UniProtKB	Natural variant	224	224	.	.	.	ID=VAR_002181;Note=In CBSD. R->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8528202;Dbxref=dbSNP:rs761647392,PMID:8528202	
P35520	UniProtKB	Natural variant	226	226	.	.	.	ID=VAR_008070;Note=In CBSD%3B presents 20%25 of the wild-type activity%3B dramatically reduced capacity to form multimeric quaternary structure. A->T;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:14635102,ECO:0000269|PubMed:16429402;Dbxref=dbSNP:rs763835246,PMID:14635102,PMID:16429402	
P35520	UniProtKB	Natural variant	228	228	.	.	.	ID=VAR_021794;Note=In CBSD%3B loss of cystathionine beta-synthase activity%3B decreased homotetramer formation. N->K;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12124992,ECO:0000269|PubMed:15146473,ECO:0000269|PubMed:20506325,ECO:0000269|PubMed:9889017;Dbxref=dbSNP:rs1464223176,PMID:12124992,PMID:15146473,PMID:20506325,PMID:9889017	
P35520	UniProtKB	Natural variant	228	228	.	.	.	ID=VAR_046928;Note=In CBSD%3B has significantly decreased levels of enzyme activity. N->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14635102;Dbxref=PMID:14635102	
P35520	UniProtKB	Natural variant	231	231	.	.	.	ID=VAR_046929;Note=In CBSD%3B has significantly decreased levels of enzyme activity. A->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14635102;Dbxref=PMID:14635102	
P35520	UniProtKB	Natural variant	234	234	.	.	.	ID=VAR_008071;Note=In CBSD%3B decreased cystathionine beta-synthase activity%3B changed localization%3B decreased interaction with pyridoxal 5'-phosphate%3B no effect on homotetramer formation. D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23981774;Dbxref=dbSNP:rs773734233,PMID:23981774	
P35520	UniProtKB	Natural variant	234	234	.	.	.	ID=VAR_046930;Note=In CBSD%3B protein expression is comparable to wild-type%3B significant decrease of enzyme activity. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16205833;Dbxref=PMID:16205833	
P35520	UniProtKB	Natural variant	239	239	.	.	.	ID=VAR_002182;Note=In CBSD. E->K	
P35520	UniProtKB	Natural variant	247	256	.	.	.	ID=VAR_046931;Note=In CBSD. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15365998;Dbxref=PMID:15365998	
P35520	UniProtKB	Natural variant	257	257	.	.	.	ID=VAR_002183;Note=In CBSD%3B moderate to severe form%3B protein expression is comparable to wild-type%3B significant decrease of enzyme activity. T->M;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16205833,ECO:0000269|PubMed:7762555;Dbxref=dbSNP:rs758236584,PMID:16205833,PMID:7762555	
P35520	UniProtKB	Natural variant	262	262	.	.	.	ID=VAR_008072;Note=In CBSD%3B moderate form. T->M;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:9361025,ECO:0000269|PubMed:9889017;Dbxref=dbSNP:rs149119723,PMID:9361025,PMID:9889017	
P35520	UniProtKB	Natural variant	262	262	.	.	.	ID=VAR_021795;Note=In CBSD%3B severe form%3B loss of cystathionine beta-synthase activity%3B loss of homotetramer formation. T->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11013450,ECO:0000269|PubMed:20506325;Dbxref=PMID:11013450,PMID:20506325	
P35520	UniProtKB	Natural variant	266	266	.	.	.	ID=VAR_008073;Note=In CBSD. R->G	
P35520	UniProtKB	Natural variant	266	266	.	.	.	ID=VAR_008074;Note=In CBSD%3B mild form%3B decreased cystathionine beta-synthase activity%3B decreased homotetramer formation%3B no effect on heme-binding%3B decreased stability. R->K;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:20506325,ECO:0000269|PubMed:22738154,ECO:0000269|PubMed:9361025;Dbxref=dbSNP:rs121964969,PMID:20506325,PMID:22738154,PMID:9361025	
P35520	UniProtKB	Natural variant	269	269	.	.	.	ID=VAR_074591;Note=In CBSD%3B loss of expression. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23974653;Dbxref=PMID:23974653	
P35520	UniProtKB	Natural variant	270	270	.	.	.	ID=VAR_008075;Note=In CBSD. Missing	
P35520	UniProtKB	Natural variant	275	275	.	.	.	ID=VAR_021796;Note=In CBSD%3B severe form%3B exhibits an activity lower than 4%25 of the wild-type enzyme%3B absent capacity to form multimeric quaternary structure. C->Y;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12815602,ECO:0000269|PubMed:16429402;Dbxref=PMID:12815602,PMID:16429402	
P35520	UniProtKB	Natural variant	278	278	.	.	.	ID=VAR_066100;Note=In CBSD%3B loss of activity. I->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21520339;Dbxref=PMID:21520339	
P35520	UniProtKB	Natural variant	278	278	.	.	.	ID=VAR_002184;Note=In CBSD%3B mild to severe form%3B common mutation%3B decreased expression%3B loss of cystathionine beta-synthase activity%3B impaired stimulation by AdoMet and AdoHcy%3B severely affects homotetramer formation by promoting formation of larger aggregates. I->T;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11013450,ECO:0000269|PubMed:11359213,ECO:0000269|PubMed:12007221,ECO:0000269|PubMed:12124992,ECO:0000269|PubMed:1301198,ECO:0000269|PubMed:14635102,ECO:0000269|PubMed:15146473,ECO:0000269|PubMed:15993874,ECO:0000269|PubMed:20506325,ECO:0000269|PubMed:21240075,ECO:0000269|PubMed:23974653,ECO:0000269|PubMed:7506602,ECO:0000269|PubMed:7611293,ECO:0000269|PubMed:8528202,ECO:0000269|PubMed:8803779,ECO:0000269|PubMed:9156316,ECO:0000269|PubMed:9266356,ECO:0000269|PubMed:9361025,ECO:0000269|PubMed:9889017;Dbxref=dbSNP:rs5742905,PMID:11013450,PMID:11359213,PMID:12007221,PMID:12124992,PMID:1301198,PMID:14635102,PMID:15146473,PMID:15993874,PMID:20506325,PMID:21240075,PMID:23974653,PMID:7506602,PMID:7611293,PMID:8528202,PMID:8803779,PMID:9156316,PMID:9266356,PMID:9361025,PMID:9889017	
P35520	UniProtKB	Natural variant	281	281	.	.	.	ID=VAR_066101;Note=In CBSD%3B loss of activity. D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21520339;Dbxref=PMID:21520339	
P35520	UniProtKB	Natural variant	288	288	.	.	.	ID=VAR_046932;Note=In CBSD. A->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15365998;Dbxref=PMID:15365998	
P35520	UniProtKB	Natural variant	288	288	.	.	.	ID=VAR_046933;Note=In CBSD%3B protein expression is comparable to wild-type%3B significant decrease of enzyme activity. A->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16205833;Dbxref=dbSNP:rs141502207,PMID:16205833	
P35520	UniProtKB	Natural variant	290	290	.	.	.	ID=VAR_002185;Note=In CBSD. P->L;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:7564249,ECO:0000269|PubMed:8803779;Dbxref=dbSNP:rs760912339,PMID:7564249,PMID:8803779	
P35520	UniProtKB	Natural variant	302	302	.	.	.	ID=VAR_008076;Note=In CBSD%3B no effect on cystathionine beta-synthase activity%3B inhibited by AdoHcy and impaired activation by AdoMet%3B no effect on homotetramer formation. E->K;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10408774,ECO:0000269|PubMed:12124992,ECO:0000269|PubMed:20506325;Dbxref=dbSNP:rs779270933,PMID:10408774,PMID:12124992,PMID:20506325	
P35520	UniProtKB	Natural variant	305	305	.	.	.	ID=VAR_008077;Note=In CBSD%3B loss of cystathionine beta-synthase activity%3B no effect on homotetramer formation. G->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20506325;Dbxref=PMID:20506325	
P35520	UniProtKB	Natural variant	307	307	.	.	.	ID=VAR_002186;Note=In CBSD%3B moderate to severe form%3B linked with D-534%3B common mutation%3B loss of cystathionine beta-synthase activity%3B impaired stimulation by AdoMet and AdoHcy%3B no effect on homotetramer formation. G->S;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12124992,ECO:0000269|PubMed:14635102,ECO:0000269|PubMed:20506325,ECO:0000269|PubMed:7506602,ECO:0000269|PubMed:8528202,ECO:0000269|PubMed:9266356,ECO:0000269|PubMed:9361025,ECO:0000269|PubMed:9889017;Dbxref=dbSNP:rs121964962,PMID:12124992,PMID:14635102,PMID:20506325,PMID:7506602,PMID:8528202,PMID:9266356,PMID:9361025,PMID:9889017	
P35520	UniProtKB	Natural variant	320	320	.	.	.	ID=VAR_008078;Note=In CBSD%3B has 36%25 of wild-type enzyme activity. V->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:14635102,ECO:0000269|PubMed:9361025;Dbxref=dbSNP:rs781567152,PMID:14635102,PMID:9361025	
P35520	UniProtKB	Natural variant	321	321	.	.	.	ID=VAR_066102;Note=In CBSD%3B loss of activity. D->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21520339;Dbxref=PMID:21520339	
P35520	UniProtKB	Natural variant	331	331	.	.	.	ID=VAR_008079;Note=In CBSD. A->E;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12124992,ECO:0000269|PubMed:9156316;Dbxref=dbSNP:rs777919630,PMID:12124992,PMID:9156316	
P35520	UniProtKB	Natural variant	331	331	.	.	.	ID=VAR_002187;Note=In CBSD. A->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8528202;Dbxref=dbSNP:rs777919630,PMID:8528202	
P35520	UniProtKB	Natural variant	336	336	.	.	.	ID=VAR_002188;Note=In CBSD%3B protein expression is comparable to wild-type%3B loss of activity%3B absent capacity to form multimeric quaternary structure. R->C;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10408774,ECO:0000269|PubMed:12124992,ECO:0000269|PubMed:12815602,ECO:0000269|PubMed:16205833,ECO:0000269|PubMed:16429402,ECO:0000269|PubMed:21240075;Dbxref=dbSNP:rs398123151,PMID:10408774,PMID:12124992,PMID:12815602,PMID:16205833,PMID:16429402,PMID:21240075	
P35520	UniProtKB	Natural variant	336	336	.	.	.	ID=VAR_008080;Note=In CBSD%3B mild form%3B no effect on expression%3B exhibits an activity lower than 4%25 of the wild-type enzyme%3B altered stimulation by AdoMet%3B absent capacity to form multimeric quaternary structure. R->H;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16429402,ECO:0000269|PubMed:23974653;Dbxref=dbSNP:rs760417941,PMID:16429402,PMID:23974653	
P35520	UniProtKB	Natural variant	338	338	.	.	.	ID=VAR_021797;Note=In CBSD%3B severe form%3B exhibits an activity lower than 4%25 of the wild-type enzyme%3B absent capacity to form multimeric quaternary structure. L->P;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12815602,ECO:0000269|PubMed:16429402;Dbxref=PMID:12815602,PMID:16429402	
P35520	UniProtKB	Natural variant	347	347	.	.	.	ID=VAR_021798;Note=In CBSD%3B protein expression is comparable to wild-type%3B loss of activity. G->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12124992,ECO:0000269|PubMed:16205833;Dbxref=dbSNP:rs771298943,PMID:12124992,PMID:16205833	
P35520	UniProtKB	Natural variant	349	349	.	.	.	ID=VAR_021799;Note=In CBSD%3B severe form%3B exhibits an activity lower than 4%25 of the wild-type enzyme%3B absent capacity to form multimeric quaternary structure. S->N;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12815602,ECO:0000269|PubMed:16429402;Dbxref=PMID:12815602,PMID:16429402	
P35520	UniProtKB	Natural variant	352	352	.	.	.	ID=VAR_008081;Note=In CBSD. S->N	
P35520	UniProtKB	Natural variant	353	353	.	.	.	ID=VAR_008082;Note=In CBSD%3B protein expression is comparable to wild-type%3B significant decrease of enzyme activity. T->M;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12124992,ECO:0000269|PubMed:14635102,ECO:0000269|PubMed:16205833,ECO:0000269|PubMed:9156316;Dbxref=dbSNP:rs121964972,PMID:12124992,PMID:14635102,PMID:16205833,PMID:9156316	
P35520	UniProtKB	Natural variant	354	354	.	.	.	ID=VAR_008083;Note=In CBSD. V->M;Dbxref=dbSNP:rs267606146	
P35520	UniProtKB	Natural variant	355	355	.	.	.	ID=VAR_021800;Note=In CBSD. A->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9889017;Dbxref=dbSNP:rs1192581453,PMID:9889017	
P35520	UniProtKB	Natural variant	361	361	.	.	.	ID=VAR_046934;Note=In CBSD. A->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11553052;Dbxref=dbSNP:rs745764562,PMID:11553052	
P35520	UniProtKB	Natural variant	369	369	.	.	.	ID=VAR_008084;Note=In CBSD%3B when linked with C-491 severe form%3B decreased cystathionine beta-synthase activity%3B decreased homotetramer formation. R->C;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12124992,ECO:0000269|PubMed:20506325,ECO:0000269|PubMed:9361025;Dbxref=dbSNP:rs117687681,PMID:12124992,PMID:20506325,PMID:9361025	
P35520	UniProtKB	Natural variant	369	369	.	.	.	ID=VAR_002189;Note=In CBSD. R->H;Dbxref=dbSNP:rs11700812	
P35520	UniProtKB	Natural variant	370	370	.	.	.	ID=VAR_008085;Note=In CBSD. C->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10462600;Dbxref=dbSNP:rs757920190,PMID:10462600	
P35520	UniProtKB	Natural variant	371	371	.	.	.	ID=VAR_002190;Note=In CBSD. V->M;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12124992,ECO:0000269|PubMed:7635485;Dbxref=dbSNP:rs372010465,PMID:12124992,PMID:7635485	
P35520	UniProtKB	Natural variant	376	376	.	.	.	ID=VAR_046935;Note=In CBSD%3B has significantly decreased levels of enzyme activity. D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14635102;Dbxref=dbSNP:rs1170128038,PMID:14635102	
P35520	UniProtKB	Natural variant	379	379	.	.	.	ID=VAR_021801;Note=In CBSD%3B exhibits an activity lower than 4%25 of the wild-type enzyme%3B absent capacity to form multimeric quaternary structure. R->Q;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12815602,ECO:0000269|PubMed:16429402;Dbxref=dbSNP:rs763036586,PMID:12815602,PMID:16429402	
P35520	UniProtKB	Natural variant	379	379	.	.	.	ID=VAR_046936;Note=In CBSD. R->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15365998;Dbxref=dbSNP:rs769080151,PMID:15365998	
P35520	UniProtKB	Natural variant	384	384	.	.	.	ID=VAR_002191;Note=In CBSD%3B severe form. K->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8990018;Dbxref=dbSNP:rs121964967,PMID:8990018	
P35520	UniProtKB	Natural variant	384	384	.	.	.	ID=VAR_008086;Note=In CBSD%3B moderate form. K->N	
P35520	UniProtKB	Natural variant	391	391	.	.	.	ID=VAR_008087;Note=In CBSD. M->I	
P35520	UniProtKB	Natural variant	422	422	.	.	.	ID=VAR_021802;Note=In CBSD%3B changed cystathionine beta-synthase activity%3B impaired stimulation by AdoMet%3B does not affect homotetramer formation. P->L;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12007221,ECO:0000269|PubMed:20506325;Dbxref=dbSNP:rs28934892,PMID:12007221,PMID:20506325	
P35520	UniProtKB	Natural variant	427	427	.	.	.	ID=VAR_074592;Note=In CBSD%3B no effect on cystathionine beta-synthase activity%3B altered stimulation by AdoMet. P->L;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:23974653,ECO:0000269|PubMed:25044645;Dbxref=dbSNP:rs863223434,PMID:23974653,PMID:25044645	
P35520	UniProtKB	Natural variant	434	434	.	.	.	ID=VAR_008088;Note=In CBSD. T->N	
P35520	UniProtKB	Natural variant	435	435	.	.	.	ID=VAR_008089;Note=In CBSD%3B no effect on cystathionine beta-synthase activity%3B impaired stimulation by AdoMet and AdoHcy%3B does not affect homotetramer formation. I->T;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12007221,ECO:0000269|PubMed:20506325;Dbxref=PMID:12007221,PMID:20506325	
P35520	UniProtKB	Natural variant	439	439	.	.	.	ID=VAR_008090;Note=In CBSD%3B no effect on cystathionine beta-synthase activity%3B increased homotetramer formation. R->Q;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10462600,ECO:0000269|PubMed:12124992,ECO:0000269|PubMed:20506325,ECO:0000269|PubMed:9156316;Dbxref=dbSNP:rs756467921,PMID:10462600,PMID:12124992,PMID:20506325,PMID:9156316	
P35520	UniProtKB	Natural variant	444	444	.	.	.	ID=VAR_002192;Note=In CBSD%3B decreased expression%3B no effect on cystathionine beta-synthase activity%3B altered stimulation by AdoMet%3B increased homotetramer formation. D->N;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12007221,ECO:0000269|PubMed:20506325,ECO:0000269|PubMed:23974653,ECO:0000269|PubMed:25044645,ECO:0000269|PubMed:8755636;Dbxref=dbSNP:rs28934891,PMID:12007221,PMID:20506325,PMID:23974653,PMID:25044645,PMID:8755636	
P35520	UniProtKB	Natural variant	446	446	.	.	.	ID=VAR_066103;Note=In CBSD. A->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21520339;Dbxref=PMID:21520339	
P35520	UniProtKB	Natural variant	449	449	.	.	.	ID=VAR_074593;Note=In CBSD%3B no effect on cystathionine beta-synthase activity%3B altered stimulation by AdoMet. V->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25044645;Dbxref=PMID:25044645	
P35520	UniProtKB	Natural variant	454	454	.	.	.	ID=VAR_002193;Note=In CBSD. V->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8528202;Dbxref=PMID:8528202	
P35520	UniProtKB	Natural variant	456	456	.	.	.	ID=VAR_021803;Note=In CBSD%3B severe%3B exhibits an activity lower than 4%25 of the wild-type enzyme%3B absent capacity to form multimeric quaternary structure. L->P;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12815602,ECO:0000269|PubMed:16429402;Dbxref=PMID:12815602,PMID:16429402	
P35520	UniProtKB	Natural variant	466	466	.	.	.	ID=VAR_008091;Note=In CBSD%3B increased cystathionine beta-synthase activity%3B impaired stimulation by AdoMet and AdoHcy%3B decreased homotetramer formation. S->L;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12007221,ECO:0000269|PubMed:20506325;Dbxref=dbSNP:rs121964971,PMID:12007221,PMID:20506325	
P35520	UniProtKB	Natural variant	491	491	.	.	.	ID=VAR_008092;Note=In CBSD%3B linked with C-369. R->C;Dbxref=dbSNP:rs1339830457	
P35520	UniProtKB	Natural variant	500	500	.	.	.	ID=VAR_074594;Note=In CBSD%3B no effect on cystathionine beta-synthase activity%3B altered stimulation by AdoMet. S->L;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:23974653,ECO:0000269|PubMed:25044645;Dbxref=dbSNP:rs755106884,PMID:23974653,PMID:25044645	
P35520	UniProtKB	Natural variant	526	526	.	.	.	ID=VAR_046937;Note=In CBSD%3B has significantly decreased levels of enzyme activity. Q->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14635102;Dbxref=PMID:14635102	
P35520	UniProtKB	Natural variant	534	534	.	.	.	ID=VAR_008093;Note=In CBSD%3B linked with S-307. V->D	
P35520	UniProtKB	Natural variant	539	539	.	.	.	ID=VAR_002194;Note=In CBSD%3B loss of cystathionine beta-synthase activity%3B impaired stimulation by AdoMet and AdoHcy%3B loss of homotetramer formation. L->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:20506325,ECO:0000269|PubMed:8990018;Dbxref=dbSNP:rs121964968,PMID:20506325,PMID:8990018	
P35520	UniProtKB	Natural variant	540	540	.	.	.	ID=VAR_074595;Note=In CBSD%3B no effect on cystathionine beta-synthase activity%3B altered stimulation by AdoMet. L->Q;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:23974653,ECO:0000269|PubMed:25044645;Dbxref=PMID:23974653,PMID:25044645	
P35520	UniProtKB	Natural variant	548	548	.	.	.	ID=VAR_046938;Note=Presents 60%25 of the wild-type activity%3B highly reduced capacity to form multimeric quaternary structure. R->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16429402;Dbxref=dbSNP:rs150828989,PMID:16429402	
P35520	UniProtKB	Mutagenesis	272	272	.	.	.	Note=Reduced heme content and cystathionine beta-synthase activity. C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12173932;Dbxref=PMID:12173932	
P35520	UniProtKB	Mutagenesis	275	275	.	.	.	Note=Reduced heme content and cystathionine beta-synthase activity. C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12173932;Dbxref=PMID:12173932	
P35520	UniProtKB	Sequence conflict	58	58	.	.	.	Note=R->P;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P35520	UniProtKB	Helix	60	62	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Beta strand	75	79	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Helix	80	82	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Beta strand	83	85	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Beta strand	89	91	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Helix	95	98	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Beta strand	103	109	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Helix	110	112	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Beta strand	113	117	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4L0D	
P35520	UniProtKB	Helix	119	132	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Beta strand	141	145	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Helix	149	161	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Beta strand	164	170	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Helix	175	183	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Beta strand	187	191	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Beta strand	193	195	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5MMS	
P35520	UniProtKB	Beta strand	197	199	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4L27	
P35520	UniProtKB	Helix	203	213	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Beta strand	217	219	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4L28	
P35520	UniProtKB	Turn	222	224	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Helix	227	234	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Helix	236	243	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Turn	244	246	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Beta strand	249	254	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Beta strand	256	258	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Helix	259	271	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Beta strand	272	274	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1M54	
P35520	UniProtKB	Beta strand	276	282	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Beta strand	288	290	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Helix	291	294	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Helix	317	319	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Beta strand	322	326	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Helix	328	342	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Helix	348	360	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Helix	361	363	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Beta strand	369	374	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Helix	378	381	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Turn	382	386	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Helix	388	393	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Helix	399	404	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Turn	408	411	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4UUU	
P35520	UniProtKB	Helix	414	417	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4UUU	
P35520	UniProtKB	Helix	431	441	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4UUU	
P35520	UniProtKB	Beta strand	444	449	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4UUU	
P35520	UniProtKB	Beta strand	455	460	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4UUU	
P35520	UniProtKB	Helix	461	469	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4UUU	
P35520	UniProtKB	Helix	479	482	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4UUU	
P35520	UniProtKB	Beta strand	489	491	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4UUU	
P35520	UniProtKB	Helix	496	505	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4UUU	
P35520	UniProtKB	Beta strand	509	515	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4UUU	
P35520	UniProtKB	Beta strand	526	534	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4UUU	
P35520	UniProtKB	Helix	536	544	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4UUU	
